An observational study in Diabetes Mellitus, sponsored by Hospital Regional de Alta Especialidad del Bajio. Recruiting at 1 site in Mexico. Open to participants aged 1 Month to 17 Years. Per ClinicalTrials.gov, last updated 2017-08-22.
Sponsored by Hospital Regional de Alta Especialidad del Bajio · Observational
The aim of this study is the identification of complications in diabetes mellitus pediatric patients and to compare the clinical, anthropometric, and biochemical characteristics between children in the different types of diabetes mellitus.
Diabetes mellitus is characterized by hyperglycemia resulting from defects in insulin secretion and/or insulin resistance in target tissues. This study identify the influence of pathogenic factors on the evolution of diabetes mellitus and in the presence of chronic complications.
10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.
This study's planned enrollment of 500 is above the median of 233 across 2,220 observational studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →Hospital Regional de Alta Especialidad del Bajio is the lead sponsor of 12 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Children and adolescents (boys and girls) from 1 months to 17 years of age that had recently been diagnosed with diabetes mellitus.
Exclusion Criteria:
-
Sudden onset of symptoms and non-overweight/obese
Insidious onset of symptoms and overweight/obese
Overlap of type 1 and type2 diabetes mellitus clinical characteristics
According American Diabetes Association criteria
Diabetic retinopathy
A microvascular complication determined by ophthalmological evaluation
Time frame: year 3
Peripheral diabetic neuropathy
A microvascular complication determined by neurological exam in either foot
Time frame: year 5
Nerve damage
A microvascular complication determined by nerve conduction study in either foot
Time frame: year 5
Microalbuminuria
A microvascular complication determined by urine albumin excretion \>= 30 mg/day
Time frame: annual
Cardiac function
A cardiovascular risk indicator determined by echocardiogram
Time frame: year 5
Cognitive evaluation
Determined by scores on the Mini-Mental State Examination
Time frame: year 3
Intelligence quotient evaluation
Determined by Intelligence quotient test
Time frame: year 3
Body composition
Determined by body mass index (BMI) percentiles computed from physical measurements of height and weight and corresponding percentile tables
Time frame: annual
Glycemic control
Determined by HbA1c
Time frame: annual
Beta cell function
Determined by fasting C peptide
Time frame: annual
Pancreatic autoimmunity
Determined by pancreas autoantibodies
Time frame: onset of diabetes
Insulin resistance
Determined by insulin sensitivity
Time frame: annual
Alpha cell function
Determined by glucagon
Time frame: year 5
Hyperlipidemia
Determined by lipid profile
Time frame: annual
Hypothyroidism
Determined by thyroid profile
Time frame: annual
Hypertension
Determined by collection of systolic and diastolic blood pressure and calculation of their percentile values
Time frame: annual
Plan to share: Undecided
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Regional de Alta Especialidad del Bajio